HALO Hybrid Fractional Laser
World's first hybrid fractional laser combining ablative + non-ablative
About This Treatment
HALO by Sciton is the world's first hybrid fractional laser, simultaneously delivering 2940nm Er:YAG ablative and 1470nm diode non-ablative wavelengths from the same handpiece. This achieves both surface renewal and deep collagen remodeling in a single treatment.
Combines ablative-level results with significantly reduced downtime compared to traditional ablative lasers. Established combination protocols with BBL™ (BroadBand Light).
Mechanism of Action
2940nm ablative component precisely vaporizes damaged tissue (pigmentation, thickened keratin). 1470nm non-ablative component creates deep dermal coagulation zones, triggering HSP-mediated collagen remodeling. DTO™ provides real-time temperature control for safety and uniform results.
Indications
Expected Results
Single treatment equals 3-5 sessions of conventional fractional laser. 50-80% pigmentation improvement, significant pore reduction. Results continue improving over 3-6 months. Enhanced with BBL combination.
Clinical Evidence
Risks & Side Effects
Redness, swelling, micro-crusting (MEND) for 3-7 days. Rare PIH (especially Fitzpatrick III-VI). Sun protection essential. Transient herpes reactivation risk (prophylaxis recommended).
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition